Headquarters
1951 NW 7TH AVE STE 600, LIFE SCIENCE BLDG, MIAMI, FL 33136-1128, US
MIAMI, FL, US
DEMERX INC
From the company
DemeRx is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of addiction. It is developing DMX-1001 (oral noribogaine), an investigational therapy for alcohol use disorder, which affects over 29 million people in the U.S. The company was founded on the research of Dr. Deborah Mash on the neuroplastogen noribogaine, the active metabolite of ibogaine, aiming to restore and reset the brain's addiction circuitry.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.